Aehr Test Systems - Common Stock (AEHR)

Expanding beyond a handful of customers to 12+ accounts reduces execution risk as the company scales production.

Record $33M revenue and $150M full-year guidance signal AI semiconductor demand acceleration.

Aehr Test Systems (NASDAQ:AEHR) reported record revenue and sharply higher bookings for its fiscal 2027 first quarter, citing expanding demand for wafer-level and package-level burn-in systems used in artificial intelligence, data center and power-semiconductor applications. Revenue for the quarter

A record quarter, a bigger backlog, and a higher target. Here's what drove Aehr's swing to profit and what still has to go right.

One niche player burned cash and posted a net loss; the other generated $3.8 billion in free cash flow.

Aehr trades at a steep premium despite recent losses, while Super Micro's valuation looks cheap relative to its growth, but both carry hidden risks.

Some of the best AI stocks have been dumped in recent weeks. That trend should change soon.

Rogers trimmed his direct holdings by 3% after the stock surged 695% over the past 12 months.

Aehr Test Systems shares have surged over 400% in 2026 after new FOX-XP orders, including a $22 million deal, bolstered its backlog and FY2027 revenue guidance.

Velo3D, Aehr Test Systems, and Atlassian have all rallied recently on improving revenue, bookings, and AI-driven demand, but each faces distinct risks to sustaining momentum.

The insider disposed of 40,000 shares, representing a 10% reduction in total holdings.

The insider's sale followed a 484% one-year total return for the stock.

The semiconductor test company reported another insider disposition amid its stock's 477% one-year return.

Microsoft has posted eight straight quarters of revenue growth, while its smaller peer swung between sharp gains and declines.

The company reported a notable insider sale that reduced their indirect holdings by 21% as the stock surged 470% over the past year.

Both companies are burning cash and trading at steep multiples, but their paths to profitability, and their risks, couldn't be more different.

The stock continues to trade as a proxy for AI semiconductor investment, and for good reason.

Aehr Test System (NASDAQ:AEHR) has outperformed the market over the past 10 years by 34.67% on an annualized basis producing an average annual return of 47.7%. Currently, Aehr Test System has a market capitalization of

Gainers Greenidge Generation (NASDAQ:GREE) stock increased by 34.7% to $2.87 during Tuesday's regular session. The market value of their outstanding shares is at $38.3 million. Aehr Test System (NASDAQ:AEHR)

Aehr Test Systems beat quarterly estimates and issued FY2027 revenue guidance of $130-$150 million, backed by a $100.6 million backlog and improved gross margins.

The company's burgeoning order growth is a good indicator of investment in AI processors.

The AI chip tester's revenue could triple in fiscal 2027.